KALA BIO
KALA
15 hedge funds and large institutions have $4.88M invested in KALA BIO in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
1,033% more capital inflows, than outflows
Capital inflows: $758K | Capital outflows: $66.9K
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
15% more funds holding
Funds holding: 13 → 15 (+2)
3.38% more ownership
Funds ownership: 19.55% → 22.93% (+3.4%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS O'Connor
Chicago,
Illinois
|
+$535K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$100K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$100K |
| 4 |
Millennium Management
New York
|
+$11.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$22.3K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$22.3K |
| 3 |
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
-$11.1K |
| 4 |
Renaissance Technologies
New York
|
-$11.1K |
KALA Hedge Fund Activity: Q1 2024 in Review
15 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2024, worth a combined $4.88M — up 33% from $3.68M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KALA positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $535K. The largest seller was Bank of America, exiting entirely with an estimated $22.3K sold.
- 15 institutional investors held KALA BIO (KALA) as of Q1 2024, up from 13 in Q4 2023.
- Funds reported $4.88M of KALA BIO stock for Q1 2024, up 33% quarter-over-quarter.
- 3 funds opened new KALA BIO positions in Q1 2024 and 1 closed out, a net change of +2 holders.
- The largest KALA BIO buyer in Q1 2024 was UBS O'Connor, an estimated $535K added.
- The largest KALA BIO seller in Q1 2024 was Bank of America, an estimated $22.3K sold.
Based on aggregated 13F filings for Q1 2024.